These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 25283814)
21. Comparison of biochemical failure definitions for predicting local cancer recurrence following cryoablation of the prostate. Pitman M; Shapiro EY; Hruby GW; Truesdale MD; Cheetham PJ; Saad S; Katz AE Prostate; 2012 Dec; 72(16):1802-8. PubMed ID: 22618738 [TBL] [Abstract][Full Text] [Related]
22. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Eisenberg ML; Shinohara K Urology; 2008 Dec; 72(6):1315-8. PubMed ID: 18597824 [TBL] [Abstract][Full Text] [Related]
23. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer. Kvorning Ternov K; Krag Jakobsen A; Bratt O; Ahlgren G Scand J Urol; 2015 Apr; 49(2):115-9. PubMed ID: 25428754 [TBL] [Abstract][Full Text] [Related]
24. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System. Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS Perm J; 2019; 23():. PubMed ID: 31050644 [TBL] [Abstract][Full Text] [Related]
25. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen. Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721 [TBL] [Abstract][Full Text] [Related]
26. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population. Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496 [TBL] [Abstract][Full Text] [Related]
28. Focal Salvage MR Imaging-Guided Cryoablation for Localized Prostate Cancer Recurrence after Radiotherapy: 12-Month Follow-up. Bomers JGR; Overduin CG; Jenniskens SFM; Cornel EB; van Lin ENJT; Sedelaar JPM; Fütterer JJ J Vasc Interv Radiol; 2020 Jan; 31(1):35-41. PubMed ID: 31735483 [TBL] [Abstract][Full Text] [Related]
29. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery. Chang JH; Park W; Park JS; Pyo H; Huh SJ; Choi HY; Lee HM; Jeon SS; Seo SI Int J Urol; 2015 Jan; 22(1):82-7. PubMed ID: 25208624 [TBL] [Abstract][Full Text] [Related]
30. Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry. Dhar N; Ward JF; Cher ML; Jones JS BJU Int; 2011 Aug; 108(4):508-12. PubMed ID: 21722288 [TBL] [Abstract][Full Text] [Related]
31. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241 [TBL] [Abstract][Full Text] [Related]
32. Salvage cryosurgery for locally recurrent prostate cancer following radiotherapy. Ahmed S; Lindsey B; Davies J Prostate Cancer Prostatic Dis; 2005; 8(1):31-5. PubMed ID: 15583704 [TBL] [Abstract][Full Text] [Related]
33. Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry. Ward JF; DiBlasio CJ; Williams C; Given R; Jones JS BJU Int; 2014 May; 113(5):714-8. PubMed ID: 24112776 [TBL] [Abstract][Full Text] [Related]
34. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068 [TBL] [Abstract][Full Text] [Related]
35. Salvage Cryoablation and Robotic Seminal Vesiculectomy: A Novel Salvage Treatment for Locally Recurrent Prostate Cancer. Smigelski MB; Wysock J; Taneja SS; Lepor H J Endourol; 2023 Aug; 37(8):876-881. PubMed ID: 37300480 [No Abstract] [Full Text] [Related]
36. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry. Spiess PE; Levy DA; Pisters LL; Mouraviev V; Jones JS World J Urol; 2013 Dec; 31(6):1321-5. PubMed ID: 23179729 [TBL] [Abstract][Full Text] [Related]
37. [Salvage cryotherapy for recurrent prostate cancer after radiotherapy failure: principles, indications, patient selection, oncological results and morbidity]. Hétet JF; Colls P; Pocholle P; Chauveau P; Barré C; Hallouin P Cancer Radiother; 2014 Nov; 18(7):701-8. PubMed ID: 24910288 [TBL] [Abstract][Full Text] [Related]
38. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165 [TBL] [Abstract][Full Text] [Related]
39. Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation. Ginsburg KB; Elshafei A; Yu C; Jones JS; Cher ML Prostate; 2017 Oct; 77(14):1446-1450. PubMed ID: 28856702 [TBL] [Abstract][Full Text] [Related]
40. Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review. Duijzentkunst DA; Peters M; van der Voort van Zyp JR; Moerland MA; van Vulpen M World J Urol; 2016 Nov; 34(11):1521-1531. PubMed ID: 27012712 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]